Medicare said Tuesday it will limit coverage of a $28,000ayear Alzheimer's drug whose benefits have been widely questioned, a major development in the nation's tugofwar over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices.
from Top Business News- News18.com https://ift.tt/3GvOWna
via IFTTT
0 Comments